Article Text
Commentary
Cochrane neurological network corner
Commentary on “Immunosuppressant drugs for myasthenia gravis”
Statistics from Altmetric.com
The choice of treatments for this chronic, disabling yet rare disorder is limited and founded on a weak evidence base. The conclusion that corticosteroid treatment offers significant short-term benefit is based on sources of evidence …
Footnotes
-
Competing interests: None.
Linked Articles
- Cochrane neurological network corner